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INTRODUCTION
Lung cancer is the second most common nonskin cancer in both men and women and is the leading cause of cancer related death [1] . The majority of lung cancers are non-small cell (NSCLC) [2] and primary treatment options are surgery, radiation and chemotherapy. Early stage NSCLC patients, who can tolerate surgical resection have approximately 60-80% survival rate over 5 years [3] . For those patients ineligible for surgery, the standard of care is radiation therapy, which historically results in a much lower 5-year overall survival (6-30%) [4] . Conventional fractionated radiation therapy (CFRT) consists of 30 small daily fractions (typically, 2 Gy/ fraction). However, recent clinical trials indicate that hypofractionated stereotactic body radiation therapy
The typical regimen (3 x 12 to 16 Gy) is delivered in 1½ to 2 weeks [6] . With fewer patient visits, customized treatment planning based on individualized tumor characteristics has become a possibility, implying the opportunity for precision medicine. Hypoxia is recognized to play an important role in radiation resistance [7] [8] [9] . Historical evidence suggests that reoxygenation occurs during CFRT, but SBRT offers less opportunity [10] . Initial hypoxia and temporal To investigate tumor oxygenation and changes in response to high dose irradiation, we investigated the A549 tumor implanted subcutaneously as a xenograft in nude rats. The A549 is a popular tumor research model of human disease, but historically most investigations were performed in cell culture or in xenografts implanted in immune compromised mice [12] [13] [14] [15] [16] [17] . In vitro studies indicate that A549 cells are relatively radioresistant with several reports over the years consistently indicating about 80% cell death at 6 Gy [17] [18] [19] [20] .
A549 tumor is reported to be very hypoxic with 80% of measurements showing pO 2 <2.5 Torr using polarographic oxygen electrodes for subcutaneous tumors in mice [21] . Substantial uptake of bioreductively activated nitroimidazoles has revealed hypoxia based on the SPECT agent Tc-HL91 (Prognox) [21] , the PET and immunohistochemistry [23] . Hypoxia was readily modulated with hyperoxic gas breathing (oxygen or carbogen plus nicotinamide) [21, 22] . Several irradiation growth delay. A single dose of 5 Gy caused tumor growth delay, but growth continued (50% over 14 days) [19] . Even 2x20 Gy caused only 20 day growth delay [24] . Several reports indicate that tumor hypoxia, perfusion and vascular permeability are altered following high dose irradiation to various tumor types [25] [26] [27] [28] [29] [30] including A549 in mice [23] .
Non-invasive measurements of tumor hypoxia would be particularly attractive for tumor progression and treatment planning. In this study, we applied two oxygen enhanced MRI techniques blood oxygen level dependent (BOLD) [31, 32] and tissue oxygen level dependent (TOLD) [33] [34] [35] MRI to assess vascular oxygenation and tissue oxygenation, respectively. It is reported that tumor BOLD and TOLD responses to oxygen breathing challenge can provide information on tumor oxygenation [36] [37] [38] [39] , which could be easily implemented into clinical practice [36, [40] [41] [42] . In addition, we applied DCE (Dynamic Contrast Enhanced) MRI to assess the vascular perfusion and tumor pathophysiology. We used these MRI techniques to evaluate the acute and chronic sequelae of high dose irradiation at 24 hrs and 1 week, as part of a three x 12 Gy irradiation protocol of subcutaneous A549 human lung tumor xenografts implanted in nude rats.
RESULTS
The take rate of A549 tumors implanted subcutaneously in nude rats was sub optimal. With whole body irradiation (3 Gy) 48 hrs prior to implantation 27 tumors developed, but 10 regressed spontaneously. The remaining 17 showed somewhat variable growth rates with volume doubling times in the range 16 to 36 days and 13 were included in this study. Rats were divided into three groups: Group 1 served as control (n=3; tumor volume = 1,200±700 mm 3 , ranging from 600 to 2,000 mm No recurrence of primary tumors was observed. One tumor did remain at relatively constant volume, while all other treated tumors essentially disappeared, but all rats were due to development of metastases (in pelvis and lung).
comparison with reference to ATCC. Group 3 (n = 3; 800±200 mm 3 , ranging from 600 to 1,000 mm 3 ) breathed oxygen 15 minutes before and during irradiation (12 Gy histology.
Oxygen sensitive MRI (T 2 * and T 1 maps) showed distinct heterogeneity at baseline, while rats breathed air (Figures 2 and 3) . The respiratory rate was typically 30-40 breaths per minute and SAO 2 (arterial oxygen saturation) increased from 89% during air breathing to 97% with oxygen breathing (p<0.001). Rectal temperature was successfully measured in 33 of 35 studies and showed typical scan of 25 mins (maximum temperature changes 0.34±0.25°C, ranging from 0 to 0.9°C, n = 33). Moreover, MRI responses to oxygen challenge, indicating little effect of temperature on T 1 in this experimental setting. In response to oxygen breathing challenge, most tumors showed a positive BOLD signal response at baseline, in Group 1 and seven of nine tumors in Groups 2+3.
(mean ±SD) = 3.0±0.5% for Control Group 1 (n=3) and Immunohistochemistry of representative control and non-perfused, essentially avascular, regions ( Figure 7) . Notably, pimonidazole uptake, which indicates hypoxia, was greater in vascular regions, suggesting failure to reach non-perfused regions.
DISCUSSION
The majority of A549 human NSCLC xenografts grew in the thigh of nude rats following whole body irradiation and implantation of 3x10 6 cells. MRI revealed very heterogeneous multinodular structure. DCE MRI indicated little change over a period of one week for control tumors or following irradiation. Most oxygen sensitive parameters showed little change, but T 2
Figure 4: Summary of changes of oxygen sensitive parameters for irradiated group. Graphs showing mean and standard errors of the mean pre IR, 24 hours and 1 week post radiation for tumors and adjacent muscle of the irradiated (n = 9 for preIR and 24 hours; n = 6 for 1 week) and control rats (n = 3). Irradiated tumor (blue), adjacent muscle (red) control tumor (green) and muscle (purple).* p<0.05 based on paired t-test. www.impactjournals.com/oncotarget decreased following irradiation after both one and 7 days suggesting reduced vascular oxygenation. The regimen of 3x12 Gy halted tumor growth, and most tumors shrank. No recurrence was observed at the primary tumor site development of aggressive metastases after 122 to 376 days.
The A549 tumor is reported to be radioresistant [18] , but growth was essentially halted by a single dose of 12 Gy irradiation in rats breathing oxygen. Following a second dose of 12 Gy, all tumors had decreased in size and following three doses, 5 of 6 tumors essentially disappeared, while one remained as a constant 1 cm 3 nodule. No recurrence was observed at the primary site for ethical reasons, since a large mass developed in the peritoneum. Additional metastases were found in lung through necropsy. DNA was extracted from the tumor MRI revealed distinct heterogeneity in tumor anatomical structure. The relaxation parameter maps also showed wide heterogeneity with regional (voxel) [38] . The semi-quantitative BOLD response was quite similar to previous observations in relatively hypoxic large Dunning Prostate R3327-AT1 tumors [38, 39] . All these oxygen sensitive parameters were quite consistent in the control tumors when repeated after one and seven days. As expected, BOLD and T 2 * responses to oxygen breathing challenge were essentially synchronous, since the BOLD effect is derived from the third echo of the T 2 * decay curve (Figure 3 ). The TOLD response was, however, delayed slightly compared to BOLD, since oxygen and subsequent diffusion into the tissues. In response to irradiation most parameters were essentially unchanged after 24 hours and one week. BOLD time T 2 and seven days suggesting increased relaxation and greater deoxyhemoglobin. This contrasts our recent observations in radiation resistant Dunning prostate R3327-AT1 tumors, where there was evidence for reoxygenation in some tumors based on pulse chase immunohistochemistry and oxygen enhanced MRI following 15 Gy radiation, which was associated with greater tumor growth delay (based on volume quadrupling time) following a second dose of 15 Gy radiation [30] . Several studies have shown previously that BOLD and/or TOLD responses correlated with pO 2 measurements and tumor growth delay following radiation [30, 39, 44] . The utility of a TOLD (also referred to as Oxygen-enhanced) MRI response to oxygen breathing challenge to assess tumor hypoxia was thoroughly investigated and validated recently in subcutaneous 786-0 renal cancer xenografts in mice [35] . A strong correlation was observed between the fraction of tumor which failed to respond to oxygen breathing challenge (so-called Oxy-R fraction) and hypoxic fraction assessed using pimonidazole immunohistochemistry. * of water as a function of oxygen breathing challenge to evaluate potential changes in tumor oxygenation. R 1 lipid response was much greater than that of water and correlated strongly with pO 2 ESR reporter. Indeed, at 11.7 Tesla the response of the lipid at 4.0 ppm was about 11 times greater than water, whereas that at 1.3 ppm was about 2 fold. However, the approach is complicated by the need for water suppression not easily resolved from water. Lipid also exhibits relatively lower signal to noise ratio. Oddly, a follow up study examining relative R 1 responses in 9L-glioma and rhabdomyosarcoma found smaller response for lipid R 1 than water R 1 [47] . This recent work indicated that only R 2 * had predictive value with respect to tumor irradiation and this applied to subcutaneous 9L glioma in rat, but not rhabdomyosarcoma.
Dynamic contrast enhanced MRI also showed distinct intra tumor heterogeneity ( Figure 5 , Supplementary  Figure 1 ). At baseline, parameters indicated greater peripheral perfusion (e.g., TTM, AUC, slope), but with obvious well perfused inclusions, attributable to the vessels surrounding individual nodules. The control tumor indicated quite constant DCE over one week and no [48] . This is not surprising given the difference in cell density between human lung cancer A549 and rat prostate cancer AT1. It is evident in H&E that the cell density of A549 tumor ( Figure 6C ) was much lower compared to the dense tumor in AT1 subcutaneous model [49, 50] . Others have reported heterogeneity in subcutaneous A549 tumors implanted in mice with much greater enhancement in tumor periphery than center [19, 23] . Lee . Differential peripheral versus central perfusion is also seen in human lung cancer: in a study of 16 patients using dynamic contrast enhanced CT during a course of 27 Gy over three weeks the tumor center showed much lower perfusion and little variation, while the periphery showed a peak increase in vascular volume and permeability after 18 Gy [51] . There was a general lack of correlation between BOLD, TOLD and DCE parameters. However, four distinct correlations 2). The inverse correlation observed between BOLD signal 2 * and v e is to be expected since high v e (the fraction of extravascular extracellular space) is consistent with low cell density, necrosis and sparse vasculature.
As reported by others, generating A549 human tumor xenografts in nude rats is not straightforward implantation [52, 53] . It has been suggested that residual innate immunity prevents tumor development and we found that whole body irradiation two days prior to implantation was crucial to facilitate growth. In the subcutaneous setting, we also found that A549-luc cells (stably transfected to express luciferase) did not implant and grow well, even after whole body irradiation, implying potential additional immunogenicity attributable to transgene expression (unpublished results). Orthotopic implantation was more successful and new approaches to implantation and development of single nodules have been reported recently [54, 55] . However, MRI is more challenging in the orthotopic lung setting and methods are under development. The initial time for tumor development was highly variable, but once tumors reached 500 mm 3 , they showed a typical volume doubling time of 27 days (Figure 1 ). Tumors were found to grow with multi nodular structure visible by MRI (e.g., Figure  2 ) and companion histology ( Figure 6 ). The tumors also subcutaneous growth observed with many other tumor types [39] . The tumors exhibited perfusion around the whole tumor and around the individual nodules, creating highly heterogeneous vasculature observed by dynamic contrast enhanced MRI ( sizes of different tumor sublines, growing at various locations, and with respect to different irradiation doses and timing schedules. There is evidence in patients with resectable lung cancer that hypoxic tumors were associated with poor prognosis following surgery [57] . We note that motion can lead to artifacts in MRI of lung tumors and that the tissue air boundaries make lung cancer challenging, but we have reported preliminary measurements of BOLD responses (both semi-quantitative changes in signal 2 *) in human patients [58] . This study showed reduced vascular oxygenation as 2 * compared to at these times. All rats were cured of their primary tumors with 3x12 Gy, but the vascular hypoxiation may become relevant for optimizing treatment interval in future studies.
MATERIALS AND METHODS

Cell preparation
A549 (wild type) human lung cancer cells (ATCC,
Eagle's medium (DMEM) with 10% fetal bovine serum (FBS), 1% L-glutamine and 1% penicillin-streptomycin at 37 o C with 5% CO 2 the cells were harvested, and suspended in serum-free medium.
Tumor model
All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center in accordance with Federal, State, and Local laws and guidelines and consistent with Guidelines for the welfare and use of animals in cancer research [59] . Thirty anesthetized nude rats (8-10 week old female; T-cell-NCI at Frederick, Frederick, MD) were pre-treated with whole body radiation (3 Gy) to achieve additional immunosuppression and 48 hours later A549 human lung cancer cells (3x10 6 with 50% Matrigel (Corning Inc., Corning, NY)) were implanted subcutaneously in the right hind thigh [52] . The tumor volume was measured by mechanical caliper every week to determine the tumor growth based on three initiate successfully or spontaneously regressed were excluded from the study.
MRI
When the tumor volume reached 500-1,000 mm 3 , baseline MRI was performed using a horizontal bore 4.7-T magnet (Varian, Palo Alto, CA) with homebuilt 3.5 cm diameter single-turn solenoid volume coil [49] .
(1 L/min) and kept warm using a circulating warm water blanket. Animal body temperature and respiration were monitored with a small animal physiological monitoring system (Small Animal Instruments, Inc. Stony Brook, NY) throughout the experiment. A catheter was secured in the tail vein and kept in situ. T 1 maps (spin echo; TE= 20 ms, TR= 0.1, 0.2, 0.3, 0.5, 0.7, 0.9, 1.5, 2.5, 3.5 s) were acquired during initial air breathing and with oxygen challenge prior to DCE. Interleaved BOLD (multi-echo gradient echo; TR = 150 ms, ten echo times from 6 to per map) and TOLD (gradient echo; TR/TE = 30/5 ms, dynamic) MRI were acquired with the intervention of an oxygen challenge (from air to 100% O 2 after about 10 mins). With continued oxygen breathing, DCE (spin echo; TR/TE = 200/15 ms) was performed with IV injection of gadolinium contrast (0.1 mmol/kg body weight Gadovist, Schering, Berlin, Germany). MRI was performed on the treatment.
Irradiation
Twelve rats were divided into three groups: Group 1 served as control (n=3, no irradiation). Group 2 (n=6) breathed oxygen 15 minutes before and during irradiation (12 Gy x three fractions, one week interval between each treatment). Group 3 (n = 3) breathed oxygen 15 minutes before and during irradiation (12 Gy x one fraction only), the prescribed 12 Gy radiation dose was delivered with two equally weighted parallel-opposed anterior-posterior (AP) and posterior-anterior (PA) beams utilizing an image guided small animal x-ray irradiator (XRAD 225Cx, Precision X-Ray, Inc., North Branford, CT). An additional rat was used for control histology.
Data analysis
Data were processed and statistical analysis was done using Matlab. Semi-quantitative percentage signal quantitative T 1 and T 2 * maps were calculated. R 2 >0.8
Area under the curve (AUC), time-to-maximum (TTM) and slope were calculated from DCE. A reference tissue method was used for the quantitative analysis to obtain blood perfusion-vessel permeability product (K trans , unit min Histology was repeated for Group 3 rats. Following MRI, while rats continued to breathe oxygen, pimonidazole hydrochloride (Hypoxyprobe-1; NPI, Burlington, MA) was injected into the tail vein at a dose of 60 mg/kg. An additional control non-irradiated rat breathing oxygen received pimonidazole. Sixty minutes later, perfusion marker Hoechst 33342 (10 mg/kg, Life Technologies, Carlsbad, later. Tumors were dissected, oriented transaxial to match (Sakura Finetek USA, Torrence, CA). Contiguous sections in the transaxial plane were obtained on a Leica CM3050S cryostat (8 µm, Leica Microsystems, Buffalo Grove, IL) for routine hematoxylin and eosin staining (H&E), immunohistochemical detection of vascular endothelium (CD31/PECAM) and pimonidazole hypoxia marker, as well as for direct visualization of Hoechst dye uptake.
In detail, sets of four serial cryostat sections were thaw-mounted onto silanated microscope slides, air-dried later use. Subsequently, slides for immunohistochemistry immediately imaged without cover slips using illumination to detect Hoechst 33342. Following imaging for Hoechst dye, two separate and contiguous slides were subjected to differing optimized protocols for pimonidazole and CD31 immunohistochemistry. Slides intended for pimonidazole detection were readied for staining by in phosphate buffered saline (PBS, pH 7.3), prior to permeabilization in 0.1% Tween. Pimonidazole slides were then rinsed free of surfactant permeabilizer in PBS, blocked with 3.5% normal mouse serum/0.5% bovine serum albumin (BSA), and probed for one-hour incubation pimonidazole primary antibody (1:60 in 0.5% BSA/PBS; clone 4.3.11.3; NPI). Slides were washed free of unbound primary in PBS and cover slipped for later imaging. Slides intended for CD31 detection were readied for staining by PFA, pH 7.3), washing in PBS, permeabilization with 1x trypsin (10 mins at 37 °C), and an additional 5 mins goat serum/1% BSA/PBS, and probed for a day-anda-half (36-42 hrs at 4 °C) with monoclonal mouse antirat CD31 (1:10 in 1% BSA/PBS; clone TLD-3A12; BD Biosciences, San Diego, CA). CD31 slides were subsequently washed in PBS and bound primary antibody was detected by incubation with Cy3-conjugated goat antimouse secondary antibody (Jackson Immuno Research Labs, West Grove, PA). CD31 slides were washed free of unbound secondary in PBS and cover slipped for later imaging.
Pimonidazole and CD31 immunohistochemistry slides were both cover slipped with Vectashield PFA, rinsed and then subjected to a progressive staining line containing Leica Selectech reagents (Hematoxylin 560 and Alcoholic Eosin-Y 515) according to well established standard protocols. At the time of imaging, comprise the entire tumor and surrounding tissue at 10x photomicroscope (Melville, NY) equipped with epi-OR) and Nikon DS-Fi2 CCD camera. Stage registry, illumination and camera were controlled by Nikon Imaging Solution Elements v4.20.00 software. Final scanned images ranging from 11844 x 10632 pixels to 16348 x 15330 pixels were parsed into registry and overlaid using Nikon Elements 4.20.00 and Adobe Photoshop CS4 (Adobe Systems, San Jose, CA).
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